div class=ts-pagebutton class=gotoPage data-page=1Page 1button div class=ts-imageimg data-url=coreacuk-2017-3-23-nant-tumor-in-korea-comprising-307-of-all-malignancyhtmlpage=1 data-page=1 class=ts-thumb lazyload alt=Page 1: coreacuk · 2017 3 23 · nant tumor in Korea comprising 307% of all malignancy during period of study Among malignant lymphomas non-Hodgkins lymphoma accounted for 82% and loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader033vdocumentssitereader033viewer202206091060a46e31e4d2b25c6d74504chtml5thumbnails1jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=2Page 2button div class=ts-imageimg data-url=coreacuk-2017-3-23-nant-tumor-in-korea-comprising-307-of-all-malignancyhtmlpage=2 data-page=2 class=ts-thumb lazyload alt=Page 2: coreacuk · 2017 3 23 · nant tumor in Korea comprising 307% of all malignancy during period of study Among malignant lymphomas non-Hodgkins lymphoma accounted for 82% and loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader033vdocumentssitereader033viewer202206091060a46e31e4d2b25c6d74504chtml5thumbnails2jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=3Page 3button div class=ts-imageimg data-url=coreacuk-2017-3-23-nant-tumor-in-korea-comprising-307-of-all-malignancyhtmlpage=3 data-page=3 class=ts-thumb lazyload alt=Page 3: coreacuk · 2017 3 23 · nant tumor in Korea comprising 307% of all malignancy during period of study Among malignant lymphomas non-Hodgkins lymphoma accounted for 82% and loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader033vdocumentssitereader033viewer202206091060a46e31e4d2b25c6d74504chtml5thumbnails3jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=4Page 4button div class=ts-imageimg data-url=coreacuk-2017-3-23-nant-tumor-in-korea-comprising-307-of-all-malignancyhtmlpage=4 data-page=4 class=ts-thumb lazyload alt=Page 4: coreacuk · 2017 3 23 · nant tumor in Korea comprising 307% of all malignancy during period of study Among malignant lymphomas non-Hodgkins lymphoma accounted for 82% and loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader033vdocumentssitereader033viewer202206091060a46e31e4d2b25c6d74504chtml5thumbnails4jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=5Page 5button div class=ts-imageimg data-url=coreacuk-2017-3-23-nant-tumor-in-korea-comprising-307-of-all-malignancyhtmlpage=5 data-page=5 class=ts-thumb lazyload alt=Page 5: coreacuk · 2017 3 23 · nant tumor in Korea comprising 307% of all malignancy during period of study Among malignant lymphomas non-Hodgkins lymphoma accounted for 82% and loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader033vdocumentssitereader033viewer202206091060a46e31e4d2b25c6d74504chtml5thumbnails5jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=6Page 6button div class=ts-imageimg data-url=coreacuk-2017-3-23-nant-tumor-in-korea-comprising-307-of-all-malignancyhtmlpage=6 data-page=6 class=ts-thumb lazyload alt=Page 6: coreacuk · 2017 3 23 · nant tumor in Korea comprising 307% of all malignancy during period of study Among malignant lymphomas non-Hodgkins lymphoma accounted for 82% and loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader033vdocumentssitereader033viewer202206091060a46e31e4d2b25c6d74504chtml5thumbnails6jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=7Page 7button div class=ts-imageimg data-url=coreacuk-2017-3-23-nant-tumor-in-korea-comprising-307-of-all-malignancyhtmlpage=7 data-page=7 class=ts-thumb lazyload alt=Page 7: coreacuk · 2017 3 23 · nant tumor in Korea comprising 307% of all malignancy during period of study Among malignant lymphomas non-Hodgkins lymphoma accounted for 82% and loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader033vdocumentssitereader033viewer202206091060a46e31e4d2b25c6d74504chtml5thumbnails7jpg width=140 height=200 divdiv
